UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                       Washington, D. C. 20549

                              FORM 8-K

                           CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  September 15, 2003

                         HEMACARE CORPORATION
         (Exact Name of Registrant as Specified in its Charter)

                              CALIFORNIA
            (State or other jurisdiction of incorporation)

     000-15223                                95-3280412
(Commission File No.)             (IRS Employer Identification No.)

                       21101 Oxnard Street
                     Woodland Hills, CA 91367
         (Address of principal executive offices and Zip Code)

Registrant's telephone number, including area code: (818) 226-1968




ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

(c) Exhibits

Exhibit Number	  Description
--------------    -----------------------------------------------

99.1	          Press Release issued by HemaCare, dated
                  September 15, 2003


Item 9.   REGULATION FD DISCLOSURE

On September 15, 2003, HemaCare Corporation issued a press release
announcing the closure of some of its blood management programs in
order to achieve sustained profitability. A copy is attached as
Exhibit 99.1 to this report and is
incorporated herein by reference.

The information in this Current Report on Form 8-K, including
the exhibits, will not be treated as "filed" for the purposes of
Section 18 of the Securities and Exchange Act of 1934 (the
"Exchange  Act") or otherwise subject to the liabilities of that
section.  This information will not be incorporated by reference
into a filing under the Securities Act of 1933, or into another
filing under the Exchange Act, unless that filing expressly
refers to specific information in this report.

                            SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.


Date: September 15, 2003	    HEMACARE CORPORATION

                                    /s/ Judi Irving
                                    -------------------------
				    Judi Irving,
                                    Chief Executive Officer



                         EXHIBIT INDEX

Exhibit Number   Description
--------------   -----------------------------------------------
99.1		 Press Release issued by HemaCare, dated
                 September 15, 2003